CXCL12 and follicular lymphoma: CXCL12+ stromal cells derived from both bone marrow and tonsils (LN-like FRCs) of healthy donors can attract malignant B cells and appear to enhance the survival of follicular lymphoma B cells compared with healthy B cells isolated from blood [36].